Cell Source, Inc. (CLCS) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2024 | -$3.84M | +11.2% |
| 2023 | -$4.33M | -3.6% |
| 2022 | -$4.18M | -3.9% |
| 2021 | -$4.02M | -10.5% |
| 2020 | -$3.64M | +4.4% |
| 2019 | -$3.81M | -89.7% |
| 2018 | -$2.01M | +12.5% |
| 2017 | -$2.29M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2024 | -$3.84M | +11.2% |
| 2023 | -$4.33M | -3.6% |
| 2022 | -$4.18M | -3.9% |
| 2021 | -$4.02M | -10.5% |
| 2020 | -$3.64M | +4.4% |
| 2019 | -$3.81M | -89.7% |
| 2018 | -$2.01M | +12.5% |
| 2017 | -$2.29M | — |